Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

iPacemaker Device

iPacemaker Device

By IPACEMAKER S.R.L.

iPacemaker Device is a technical encyclopedia for implantable cardiac hardware, providing datasheets and compatibility tools to healthcare professionals on iOS and Android.

The App DNA

What makes this app unique?

Clinicians hire this app to reduce reliance on manufacturer support calls and ensure patient safety during MRI procedures, fulfilling a critical point-of-care reference need.

For Healthcare professionals, cardiac technicians, and medical staff involved in the management of implantable cardiac devices.

What does it look like?

Key features

Multibrand MRI Compatibility Evaluatoredge

Software tool calculating system-wide MRI safety for combined device and lead configurations across different manufacturers

Device Databaseedge

Repository of technical specifications, physical dimensions, and programming parameters for over 7,000 cardiac devices

How much does it cost?

freemiumFree access to core database and toolsIn-app purchases for professional content

The app uses IAP to gate professional content while maintaining a free database for acquisition.

Velocity

Intense developmentShow more...

3 versions in history. Development pace: intense.

See all version history

Who built it?

IPACEMAKER S.R.L.

2 apps tracked · Medical

iPacemaker AI Follow-upiPacemaker AI Follow-up
Explore the full publisher profile

User Sentiment

What do users think recently?

Fresh user feedback skews frustrated. Users appreciate extensive device information serves as a reliable reference tool for cardiac rhythm specialists.

How are ratings & reviews evolving?

App Store
4.65 · 347
Google Play
3.56 · 44

What users say, by theme

What Users Love
  • Extensive device information serves as a reliable reference tool for cardiac rhythm specialists
What Frustrates Users
  • Subscription model implementation restricts access to previously purchased content for long-term users

17 of 17 recent reviews analyzed · moderate confidence · Frustrated overall

Read the full review analysis

Competition

Competitive landscape for iPacemaker Device

How's the Medical market?

iPacemaker Device maintains a niche presence in the Medical category, ranking #79 in US grossing and #10 in Italy. The disparity between free utility and grossing rank indicates monetization friction.

Read the market outlook

The rivals identified

UpToDate
UpToDateactive nemesis

By UpToDate, Inc.

Serves as the primary clinical decision support reference for the same medical professional audience.

  • Provides comprehensive clinical evidence-based content that extends far beyond device-specific technical datasheets.
  • Integrates directly into hospital EHR workflows, creating a massive barrier to entry for standalone reference apps.
iPacemaker Device vs UpToDate

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for iPacemaker Device

Where is it heading?

Users report: The clinical reference market is consolidating around platforms that integrate into hospital workflows, leaving standalone tools like iPacemaker Device exposed. Without a rapid refresh of the device database and a resolution to the subscription access complaints, the app risks losing its position as the primary reference tool for cardiac specialists.

  • Subscription model transition triggered legacy-user churn, which compounds the negative sentiment already visible in recent reviews.
  • Database staleness regarding new hardware releases erodes professional trust, forcing users to seek alternatives for current device data.

The SWOT

Core Strengths
  • Proprietary MRI-compatibility engine creates high switching costs
  • 7,000-device database functions as a B2B reference standard
Critical Frictions 3 weaknesses inside
Growth Levers
  • Expand B2B partnerships with hospital systems
  • Integrate real-time hardware update alerts
Market Threats 2 threats identified

Next best moves

1 Pivot · 1 Invest

Audit subscription access logic because legacy users report losing previously purchased content → reduce churn

+ 1 more prioritized move

The counter-intuitive read

The subscription model's failure is not a pricing issue…

Read the full take

Feature gaps

EHR integration (available in UpToDate but absent here)

Since the last report: The app shifted to a freemium pricing model, which caused significant user churn and negative sentiment due to access issues, while the competitive narrative pivoted to emphasize MRI-compatibility as a core differentiator.

Bottom line

iPacemaker Device holds its category lead through unique MRI-compatibility tools but bleeds legacy users due to subscription friction, so revenue growth hinges on restoring access for long-term professionals and updating the core database.

Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by iPacemaker Device, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The app shifted to a freemium pricing model, which caused significant user churn and negative sentiment due to access issues, while the competitive narrative pivoted to emphasize MRI-compatibility as a core differentiator.

shifted

Subscription to Freemium Transition

declined

Negative Sentiment and Access Complaints

improved

Feature Repositioning

added

New Weaknesses and Threats Identified

Cite this report

Marlvel.ai. “iPacemaker Device Intelligence Report.” Updated Jun 4, 2026. https://marlvel.ai/apps/it-ilpacemaker-ipacemakerplus

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0